A Research Study to Examine the Difference Between Local Anesthetics Alone and Local Anesthetics Plus Steroids in the Treatment of Chronic Headache
Migraine
About this trial
This is an interventional treatment trial for Migraine
Eligibility Criteria
Inclusion Criteria: Adult patients, age 18-65 inclusive Patients who have chronic daily headache (15 or more headache days per month) for at least 3 months prior to enrollment in the study. Headache level should be 5/10 or more at time of GON block. Patients should have posterior cervical muscle tenderness at time of nerve block. Exclusion Criteria: Patients who had surgery or any other invasive procedure in the occipital area. Patients with abnormal sensory findings on examination or any known neurological disease that may affect skin sensation (peripheral neuropathy, multiple sclerosis, stroke, etc). Patients diagnosed with cluster headache Patients with skin diseases that may affect skin sensation. Patients who are cognitively impaired. Patients with significant psychiatric disorder that may affect their understanding of the study protocol and/or their cooperation with the investigators. Patients who are pregnant or breast-feeding.
Sites / Locations
- Jefferson Headache Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Lidocaine 2%, Bupivicaine 0.5% and saline
Lidocaine 2%, Bupivicaine 0.5% and triamcinolone 40 mg
Adult patients with CDH, and headache of at least moderate intensity at time of treatment, were randomized to receive bilateral GONB and trigger point injections in the cervical paraspinal and the trapezius muscles bilaterally.
Adult patients with CDH, and headache of at least moderate intensity at time of treatment, were randomized to receive bilateral GONB and trigger point injections in the cervical paraspinal and the trapezius muscles bilaterally.